Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-28
2011-06-28
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S373100, C548S377100, C514S403000
Reexamination Certificate
active
07968584
ABSTRACT:
This invention relates to a range of 1-aryl-4-cyclopropylpyrazoles in which the cyclopropyl ring is substituted at the angular position, and pharmaceutically acceptable salts and solvates thereof, to compositions comprising such compounds, processes to their synthesis and their use as parasiticides.
REFERENCES:
patent: 6090394 (2000-07-01), Banks
patent: 6106864 (2000-08-01), Dolan et al.
patent: 6268509 (2001-07-01), Banks
patent: 7435753 (2008-10-01), Billen et al.
patent: 7514464 (2009-04-01), Billen et al.
patent: 7538134 (2009-05-01), Billen et al.
patent: 7645786 (2010-01-01), Billen et al.
patent: 2004/0013980 (2004-01-01), Hatakeyama et al.
patent: 0 605 469 (1998-02-01), None
patent: 0 959 071 (1999-11-01), None
patent: 0 933 363 (2003-08-01), None
patent: 91/11172 (1991-08-01), None
patent: 92/06973 (1992-04-01), None
patent: 93/06089 (1993-04-01), None
patent: 94/02518 (1994-02-01), None
patent: 97/07102 (1997-02-01), None
patent: 98/04530 (1998-02-01), None
patent: 98/24767 (1998-06-01), None
patent: 98/55148 (1998-10-01), None
patent: 00/35298 (2000-06-01), None
patent: 2005/060749 (2005-07-01), None
patent: 2005/090313 (2005-09-01), None
Haleblian, “Characterization of Habits and Crystalline Modification of Solids and Their Pharmaceutical Applications”, Journal of Pharmaceutical Sciences, 64(8):1269-1288, 1975.
Dolbier et al., “Trimethylsilyl fluorosulfonyldifluoroacetate (TFDA): a new, highly efficient difluorocarbene reagent”, Journal of Fluorine Chemistry, 125:459-469, 2004.
Finnin and Morgan, “Transdermal Penetration Enhancers: Applications, Limitations, and Potential”, Journal of Pharmaceutical Sciences, 88(10):955-958, 1999.
Verma and Garg, “Current Status of Drug Delivery Technologies and Future Directions”, Pharmaceutical Technology On-Line, 25(2):1-14, 2001.
Billen Denis
Boyle Jessica
Critcher Douglas James
Gethin David Morris
Hall Kim Thomas
Misiak Paul M.
Pfizer Inc.
Pfizer Products Inc.
Shameem Golam M
LandOfFree
Substituted arylpyrazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted arylpyrazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted arylpyrazoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2679729